| Online-Ressource |
Verfasst von: | Schäfer, Michaela [VerfasserIn]  |
| Oeing, Christian [VerfasserIn]  |
| Rohm, Maria [VerfasserIn]  |
| Baysal-Temel, Ezgi [VerfasserIn]  |
| Lehmann, Lorenz [VerfasserIn]  |
| Bauer, Ralf [VerfasserIn]  |
| Sticht, Carsten [VerfasserIn]  |
| Gretz, Norbert [VerfasserIn]  |
| Strobel, Oliver [VerfasserIn]  |
| Hackert, Thilo [VerfasserIn]  |
| Katus, Hugo [VerfasserIn]  |
| Berriel Diaz, Mauricio [VerfasserIn]  |
| Backs, Johannes [VerfasserIn]  |
| Herzig, Stephan [VerfasserIn]  |
Titel: | Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia |
Mitwirkende: | Boutros, Michael  |
Verf.angabe: | Michaela Schäfer, Christian U. Oeing, Maria Rohm, Ezgi Baysal-Temel, Lorenz H. Lehmann, Ralf Bauer, H. Christian Volz, Michael Boutros, Daniela Sohn, Carsten Sticht, Norbert Gretz, Katrin Eichelbaum, Tessa Werner, Marc N. Hirt, Thomas Eschenhagen, Karin Müller-Decker, Oliver Strobel, Thilo Hackert, Jeroen Krijgsveld, Hugo A. Katus, Mauricio Berriel Diaz, Johannes Backs, Stephan Herzig |
E-Jahr: | 2016 |
Jahr: | February 2016 |
Umfang: | 12 S. |
Fussnoten: | Gesehen am 22.10.2019 |
Titel Quelle: | Enthalten in: Molecular metabolism |
Ort Quelle: | Oxford [u.a.] : Elsevier, 2012 |
Jahr Quelle: | 2016 |
Band/Heft Quelle: | 5(2016), 2, Seite 67-78 |
ISSN Quelle: | 2212-8778 |
Abstract: | Objectives - Cancer cachexia affects the majority of tumor patients and significantly contributes to high mortality rates in these subjects. Despite its clinical importance, the identity of tumor-borne signals and their impact on specific peripheral organ systems, particularly the heart, remain mostly unknown. - Methods and results - By combining differential colon cancer cell secretome profiling with large-scale cardiomyocyte phenotyping, we identified a signature panel of seven “cachexokines”, including Bridging integrator 1, Syntaxin 7, Multiple inositol-polyphosphate phosphatase 1, Glucosidase alpha acid, Chemokine ligand 2, Adamts like 4, and Ataxin-10, which were both sufficient and necessary to trigger cardiac atrophy and aberrant fatty acid metabolism in cardiomyocytes. As a prototypical example, engineered secretion of Ataxin-10 from non-cachexia-inducing cells was sufficient to induce cachexia phenotypes in cardiomyocytes, correlating with elevated Ataxin-10 serum levels in murine and human cancer cachexia models. - Conclusions - As Ataxin-10 serum levels were also found to be elevated in human cachectic cancer patients, the identification of Ataxin-10 as part of a cachexokine cocktail now provides a rational approach towards personalized predictive, diagnostic and therapeutic measures in cancer cachexia. |
DOI: | doi:10.1016/j.molmet.2015.11.004 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1016/j.molmet.2015.11.004 |
| Volltext: http://www.sciencedirect.com/science/article/pii/S2212877815002161 |
| DOI: https://doi.org/10.1016/j.molmet.2015.11.004 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | Ataxin-10 |
| Cancer cachexia |
| Cardiac dysfunction |
| Fatty acid metabolism |
K10plus-PPN: | 1679363212 |
Verknüpfungen: | → Zeitschrift |
Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia / Schäfer, Michaela [VerfasserIn]; February 2016 (Online-Ressource)